Nov 06, 2019 / 01:45PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Arbutus Biopharma Corporation 2019 Third Quarter Financial Results and Corporate Update. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Pam Murphy, with Investor Relations.
Pam Murphy - Arbutus Biopharma Corporation - IR Consultant
Good morning. On the call from the Arbutus Executive Team are Bill Collier, President and Chief Executive Officer; Dave Hastings, Chief Financial Officer; Dr. Gaston Picchio, Chief Development Officer; and Dr. Mike Sofia, Chief Scientific Officer. Bill will begin with a review of corporate objectives and clinical developments, followed by Dave, who will provide a review of the company's third quarter financial results. We'll then open up the call for Q&A. Gaston and Mike will be available to address research and clinical development-related questions.
Before we begin, we'd like to remind you that some of the
Q3 2019 Arbutus Biopharma Corp Earnings Call Transcript
Feb 05, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers